PepDiana
Back to Evidence
Primary experimental recordPositive observation

PMC12830260::ACT034416

TXM-CB3

Evidence text

Paper-level observation

Fig. 1D: CB3 pretreatment (100 μM, 2 h) significantly inhibits proinflammatory cytokines IL-1β expression.
textConfidence: medium

Assay observation

Activity
Immunomodulatory
Subtype
Anti-inflammatory
Measure
fold_change
Comparator
=
Raw observation
significantly inhibited IL-1β expression relative mRNA level
Normalized measurement
=1 other
Value minimum
Not reported by source
Value maximum
Not reported by source
Target
Rattus norvegicus
Assay method
Not reported by source
Sequence
ACCPCNH
Standardization
ready simple
Assay conditions
"original_unit=relative mRNA level"

Source publication

Thioredoxin-mimetic peptide attenuates epilepsy progression and neurocognitive deficits

Redox Biology · 2026

DOI 10.1016/j.redox.2026.104021 PMC12830260
Parent mention

Related peptide identities

PEPDIA-PLP-000024

Release PepDiana-V1-20260620. The stable record URL can be cited directly in supplementary material and downstream analyses.